Trial NCT05571267

View at ClinicalTrials.gov 
Org. Study IDs: OPH2004

Last trial update was posted on 2024-02-23

MeSH Interventions

Aflibercept Bevacizumab Ranibizumab

MeSH Conditions

Macular Degeneration

Other Conditions


Stopping Reasons

Following Sponsor reassessment, OPH2004 enrollment was stopped to initiate a new Zimura wet AMD trial, OPH2007, for treatment-naïve patients. Thus, only one patient was enrolled into and completed Study OPH2004.

Limitations And Caveats

Following the Sponsor's reassessment of the Zimura development program, enrollment was stopped in this trial as the Sponsor determined that they would initiate a new Zimura wet AMD trial, the OPH2007 trial, for treatment-naïve patients. Therefore, a total of two patients were screened, one of whom was a screen failure. Thus, only one patient was enrolled into Study OPH2004.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID